← All organizations
Highest phase reached
Phase 3
First clinical trial
May 17, 2024Last known activity
Jul 14, 2025
Timeline
2010s
- Jun 1, 2018
Reprieve Cardiovascular, Inc— Founded
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (2)
- NCT06898515Lead sponsorPhase 3Jul 14, 2025
- NCT06362668Lead sponsorN/AMay 17, 2024
Details
- Founded
- Milford, MA, US Jun 1, 2018
- Last known activity
- Jul 14, 2025